Study Stopped
U.S. Department of Health and Human Services OHRP issued an FWA restriction on NYSPI research that included a pause of human subjects research as of June 23, 2023. This study will resume recruitment after OHRP has approved the resumption of research.
Boricua Youth Study COVID-19 Coping Intervention Study
THE BYS COVID-19 COPING INTERVENTION STUDY- PHASE II: A RANDOMIZED CONTROLLED TRIAL OF AN mHEALTH MINDFULNESS PROGRAM
1 other identifier
interventional
40
1 country
1
Brief Summary
The current study is the second phase of a two-part study to examine the feasibility and utility of using an mHealth mindfulness intervention to help parents mitigate the stress associated with the impact of sustained community crisis situations, such as COVID-19 and its consequences, on low-income families living in under-resourced settings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 28, 2022
CompletedFirst Submitted
Initial submission to the registry
June 24, 2022
CompletedFirst Posted
Study publicly available on registry
July 6, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2026
CompletedMarch 4, 2025
March 1, 2025
2.9 years
June 24, 2022
March 3, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Perceived Stress Scale (PSS-10)
Perceived Stress (10 items, rated 1-4, higher scores mean higher perceived stress)
Baseline, Posttreatment (6 weeks), Follow up (10-14 weeks)
Secondary Outcomes (2)
Change in Generalized Anxiety Disorder-7 (GAD-7)
Baseline, Posttreatment (6 weeks), Follow up (10-14 weeks)
Change in Patient Health Questionnaire-9 (PHQ-9)
Baseline, Posttreatment (6 weeks), Follow up (10-14 weeks)
Study Arms (2)
Intervention
EXPERIMENTAL10-20 minutes a day of mindfulness meditation practice through the Headspace app. Participants will receive daily reminders to participate and receive weekly calls to assess adherence. Participants will be briefed on the telephone on how to use the app and receive recommendations of possible meditations they can engage with throughout the 6 weeks of participation.
Waitlist Control
NO INTERVENTIONWaitlist Control
Interventions
A commercially available mindfulness mobile phone application (HeadspaceTM) will be used. The use of HeadspaceTM in the current protocol is approved by NYSPI Information Technology Services. An mHealth mindfulness program such as Headspace provides self-paced, guided mindfulness meditations through a website or mobile app (iOS and Android). The program consists of basic meditation courses as well as courses targeting stress management, anxiety, depression, and parenting. Based on the qualitative interviews with parents in Phase I, psychoeducation will be included on mindfulness practice and mental health, emphasizing basic meditation courses, and asking parents to complete daily assignments of 10 to 20 min a day during the 6-week period. As an engagement strategy, every week participants in the intervention group will receive a call or an email or text message (depends on preference; partisans may opt out to receive email/text messages).
Eligibility Criteria
You may qualify if:
- BYS participants in the NY cohort
- Have a child/children ages 3 to 12 years
- access to a smartphone, tablet, or computer with at least periodic internet access
You may not qualify if:
- Psychiatric risks (e.g., homicidally, suicidality including ideation and attempts, psychosis; answering "yes" to the PHQ-9 suicidal idea question, Q9)
- Severe depressive symptoms (i.e., PHQ-9=20 or above)
- Engagement of regular mindfulness, meditation, or yoga practice 3 or more times per week or enrollment in a mindfulness program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New York State Psychiatric Institute
New York, New York, 10032, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cristiane Duarte, PhD
New York State Psychiatric Institute
- STUDY DIRECTOR
Tenneill Murray, MPH
New York State Psychiatric Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ruane Professor for the Implementation of Science for Child and Adolescent mental Health (in Psychiatry) at CUMC
Study Record Dates
First Submitted
June 24, 2022
First Posted
July 6, 2022
Study Start
March 28, 2022
Primary Completion
February 1, 2025
Study Completion
February 1, 2026
Last Updated
March 4, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share